序贯疗法与标准三联疗法根除幽门螺杆菌的疗效对比分析——附105例报告

  • 摘要: 目的: 比较由潘托拉唑、阿莫西林、克拉霉素、替硝唑组成的10日序贯疗法与标准的7日三联疗法根除幽门螺杆菌(Hp)的疗效及安全性。方法: 将105例消化性溃疡或慢性胃炎且Hp阳性成人患者随机分为两组。治疗组(53例)前5日应用潘托拉唑40 mg、阿莫西林1 000 mg,每日2次口服,后5日用潘托拉唑40 mg、克拉霉素500 mg、替硝唑500 mg,每日2次口服。对照组(52例)采用7日潘托拉唑40 mg、阿莫西林1 000 mg、克拉霉素500 mg,每日2次口服。停药4周后复查Hp。结果: 治疗组Hp根除率为90.6%,对照组为71.2%,两组比较差异有统计学意义(P<0.05);不良反应发生率分别为18.9%和17.3%(P>0.05)。结论: 由潘托拉唑、阿莫西林、克拉霉素、替硝唑组成的10日序贯疗法治疗成人Hp感染的疗效优于标准7日三联疗法。

     

    Abstract: Objective:To evaluate the effect and safety of 10-day sequential therapy consisted of pantoprazole, clarithromycin, amoxicillin and tinidazole, and 7-day triple therapy in eradicating Helicobacter pylori(Hp) infection. Methods:One hundred and five patients of peptic ulcer and chronic gastritis with Hp-positive were randomly divided into two groups. Ten-day sequential treatment group (53 cases) was pantoprazole 40 mg, amoxicillin 1 000 mg, orally two times a day in first five days, then pantoprazole 40 mg, clarithromycin 500 mg, tinidazole 500 mg, orally two times a day in the second five days. Seven-day triple treatment group (52 cases) was pantoprazole 40 mg,clarithromycin 500 mg and amoxicillin 1 000 mg, orally two times a day for seven days. Results:The eradication rate of 10-day sequential therapy was 90.6%, and the eradication rate of 7-day triple therapy was 71.2%,the result showed a significant difference (P<0.05). The incidence rates of adverse reaction in 10-day sequential therapy group (18.9%) and 7-day triple therapy group (17.3%) were similar (P>0.05). Conclusion:The 10-day sequential therapy including pantoprazole, amoxicillin, clarithromycin and tinidazole was more effective than 7-day triple therapy on eradication of Hp infection.

     

/

返回文章
返回